Casey McPherson is an accomplished drug developer, entrepreneur and singer-songwriter based in Austin, Texas. Known for his two #10 US hits, he shifted his focus to rare genetic disease drug development after his daughter Rose was diagnosed with a rare genetic condition.

In 2020, he founded the To Cure A Rose Foundation and later founded RareLabs, a lab dedicated to developing pre-clinical treatments for rare diseases with 20 programs in the pipeline, and 8 new treatments discovered. In 2023, he launched AlphaRose Therapeutics with ex-Genzyme executives as a platform to commercialize rare genetic disease therapeutics at scale. Casey continues to build solutions for precision medicine while enjoying life with his two daughters.

McPherson briefed National Press Foundation fellows in November 2025: Rare Disease Funding Called ‘Modern-Day Civil Rights Issue.’ Check out the Rare Disease Reporting Guide.